Dr Karthik Nath | PhD scholarship | Leukaemia Foundation

Dr Karthik Nath: 2019 recipient

Dr Karthik Nath

Dr Karthik Nath, The Mater Research Institute (Brisbane).
Funding period: 2019-2022.
Project title: Integrating immunity and genetics into follicular lymphoma to establish a prognostic score fit for the modern era.

This PhD is kindly supported by the Bill Long Charitable Trust, managed by Equity Trustees.

Detailed project summary

This research undertaken by Dr Nath aims to develop a deeper understanding of the biology of Follicular Lymphoma (the second most common Non-Hodgkins Lymphoma) by employing evolving genetic and molecular laboratory technologies in prognostic paradigms.

Dr Nath and team hopes to incorporate these elements into upfront prognostication in Follicular Lymphoma that would represent a practical means of improving diagnostic techniques and treatment approaches with real-world applicability.

The second part of this research aims to help engender precision medicine in the treatment of patients with Follicular Lymphoma. By applying patient-specific immunological, molecular and genetic markers in prognostication, the research team is confident they will improve patient outcomes through individualised treatment approaches.

Utilising these highly specific markers may also help the greater research community understand disease processes and be incrementally beneficial to public health medicine. The team is hopeful individualising treatment will empower patients and reinforce the importance of psychosocial aspects involved in cancer care.

Posted on January 13th, 2020

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.

Share this page

X
X